The history of IgE: From discovery to 2010

Current Allergy and Asthma Reports

Volumn 11, Issue 2, 2011, Pages 173-177

  Johansson, S G O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ASIT; CD sens; ESIT; IgE antibody

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB; REAGINIC ANTIBODY;

ALLERGIC ASTHMA; ANTIBODY DETECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; NONHUMAN; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RADIOALLERGOSORBENT TEST; RADIOIMMUNOASSAY; REVIEW; SENSITIZATION;

ALLERGENS; ANAPHYLAXIS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOGLOBULIN E;

EID: 79955907403     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-010-0174-3     Document Type: Review

References (33)

1. Bostock J: Case of a periodical affection of the eyes and chest. Med Chir Trans 1819, 10:161.
2. Ramirez MA: Horse asthma following blood transfusion: Report on a case. JAMA 1919, 73:984-985.
3. Prausnitz C, Küstner H: Studien über die Ü berempfindlichkeit. Zentralbl Bakteriol I Abt Orig 1921, 86:160-169.
4. Coca AF, Cooke RA: On the classification of the phenomenon of hypersensitiveness. J Immunol 1923, 8:163-182.
5. Ishizaka K, Ishizaka T, Hathorn EM: Blocking of Prausnitz- Küstner sensitization with reagin by "A chain" of human γ1Aglobulin. Immunochemistry 1964, 1:197-207.
6. Ishizaka K, Ishizaka T: Identification of γE-antibodies as a carrier of reaginic activity. J Immunol 1967, 99:1187.
7. Rowe DS, Fahey JL: A new class of human immunoglobulins. II. Normal serum IgD. J Exp Med 1965, 121:185-199.
8. Stanworth DR, Humphrey JH, Bennich H, Johansson SGO: Specific inhibition of the Prausnitz-Küstner reaction by an atypical human myeloma protein. Lancet 1967, 2:330-332.
9. Johansson SGO: Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967, 2:951-953.
10. Wide L, Bennich H, Johansson SGO: Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967, 2:1105-1107.
11. Bennich HH, Ishizaka K, Johansson SGO, et al.: Immunoglobulin E, a new class of human immunoglobulin. Bull World Health Organ 1968, 38:151-152.
12. Johansson SGO, Nopp A, van Hage M, et al.: Passive IgEsensitization by blood transfusion. Allergy 2005, 60:1192-1199.
13. MarshDG: Allergens and the genetics of allergy. In: SelaM(ed.) The Antigens, vol. 3, Academic Press, New York, 1975, pp. 271-359.
14. Nopp A, Johansson SGO, Ankerst J, et al.: Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006, 61:298-302. (Pubitemid 43381805)
15. Wang H, Diepgen TL: Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005, 60:1098-1111. (Pubitemid 41153134)
16. Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A: Allergy and cancer. Allergy 2005, 60:1116-1120. (Pubitemid 41153136)
17. Vohlonen I, Terho EO, Koivikko A, et al.: Reproducibility of the skin prick test. Allergy 1989, 44:525-531. (Pubitemid 20005745)
18. NelsonHS, Oppenheimer J,Buchmeier A, et al.: An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol 1996, 97:1193-1201.
19. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC: Fatalities associated with immunotherapy and skin testing. J Allergy Clin Immunol 1987, 79:660-677. (Pubitemid 17056923)
20. Sampson HA, Ho DG: Relationship between food specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997, 100:444-451. (Pubitemid 27441298)
21. Sampson HA: Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001, 107:891-896.
22. Nopp A, Johansson SGO, Lundberg M, Öman H: Simultaneous exposure of several allergens has an additive effect on multisensitized basophils. Allergy 2006, 61:1366-1368. (Pubitemid 44465599)
23. Wahn U, Martin C, Freeman P, et al.: Relationship between pretreatment specific IgE and the response to omalizumab therapy. Allergy 2009, 64:1780-1987.
24. Valenta R, Lidholm J,NiederbergerV, et al.: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999, 29:896-904. (Pubitemid 29317799)
25. Florvaag E, Johansson SGO: The pholcodine story. Immunol Allergy Clin North Am 2009, 29:419-427.
26. Valenta R, Ferreira F, Focke-TejklM, et al.: From allergen genes to allergy vaccines. Ann Rev Immunol 2010, 28:211-241. This is an important summary of recent developments related to allergens.
27. Holgate ST, Chuchalin AG, Herbert J, et al.: Efficacy and safety of a recombinant anti-IgE antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004, 34:632-638. (Pubitemid 38534897)
28. Kleine-Tebbe J, Erdmann S, Knol EF, et al.: Diagnostic tests based human basophils: Potentials, pitfalls and perspectives. Int Arch Allergy Clin Immunol 2006, 141:79-90.
29. Johansson SGO, Nopp A, Öman H, et al.: The size of the disease relevant IgE antibody fraction in relation to "total-IgE" predicts the efficacy of anti-IgE (Xolair® ) treatment. Allergy 2009, 64:1472-1477. This study proofs that the dosage of anti-IgE must be linked to the size of the IgE antibody fraction.
30. Eckman JA, Sterba PM, Kelly D, et al.: Effects of Omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010, 125:889-895.
31. Johansson SGO, Öman H, Nopp A, Pettersson S: The importance of IgE antibody levels in anti-IgE treatment. Allergy 2006, 61:1216-1219. (Pubitemid 44326359)
32. Johansson SGO, Hourihane JO, Bousquet J, et al.: A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813-824. (Pubitemid 32800388)
33. Johansson SGO, Bieber, T, Dahl R, et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836. Without one and the same nomenclature we cannot communicate.